KRISTIN RENK: Open Payments
NPI 1508007394 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 62 payments from 3 companies in 2025. Trend: 2023 $599 · 2024 $649 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $550 |
| Novo Nordisk Inc | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
Products named: VRAYLAR, QULIPTA, UBRELVY, Ozempic, CAPLYTA.
Industry payments across OH — which companies pay providers there.
